French existentialist philosopher and Nobel laureate.
A philosophical essay exploring the "absurd" and human existence. Core Philosophy:
The fundamental question is not whether life is worth living, but how to live with inherent suffering.
Life gains greater value precisely because it lacks inherent meaning.
Selected Quotes from "The Myth of Sisyphus"
On Suicide and Philosophy "There is but one truly serious philosophical problem, and that is suicide. Judging whether life is or is not worth living amounts to answering the fundamental question of philosophy."
Meaninglessness as Liberation "Living life with no meaning allows one to live it more fully. To experience life and accept fate is to embrace existence entirely."
Living with Pain "The important thing is not to be cured, but to live with one's ailments."
Courage and Limitations "What defines a person is not their denial of eternity but their courage to live bound by reason. Courage teaches us to live unreservedly and accept limitations, even in the face of futility."
Rationality vs. Emotion "Reason is a tool of thought, not thought itself. A person’s thoughts begin with their yearnings."
Silence in Human Experience "Half of life passes in mute hesitation, averted gazes, and unspoken words."
On Intellectual Laziness "Beware those who claim, 'I understand but cannot express it.' Their inability stems from ignorance or laziness."
Wealth and Happiness "Money becomes an end in itself, overshadowing the happiness it was meant to secure."
Fate and Human Perception "Humans wrongly label only suffering as 'fate,' yet luck, too, arrives without reason."
Freedom in Mortality "Death is life's only certainty. Beyond that, humans are free—masters of a world unshackled by illusions of transcendence."
Nihilism Redefined "A nihilist is not one who believes in nothing, but one who distrusts everything as it stands."
The Illusion of Glory "The least deceptive glory is that which is witnessed firsthand."
Zhengzhou Minzhong Pharmaceutical Co., Ltd., established in 1994, is a professional enterprise that produces and sells semi-synthetic antibiotics raw materials and their formulation products. The factory is located on the Zhengbian Industrial Belt, adjacent to National Highway 107, Beijing-Hong Kong-Macau Expressway, and Longhai Railway. It is only 11 kilometers away from Zhengzhou Xinzheng International Airport, and the road, railway, and air transportation are very convenient.
The company has been committed to the research, production, and sales of the Rifamycin series of products. It always insists on science and technology as the guide and satisfies customer needs as the goal. After many years of dedicated research, it independently developed the "New Process for the Production of Rifapentine". This process won a national patent and was awarded the second prize for major scientific and technological progress in Henan Province in 2003. In June 2005, the products produced by this patent were jointly recognized as “National Key New Products” by the Ministry of Science and Technology, the Ministry of Commerce, the General Administration of Quality Supervision, and the Environmental Protection Administration, and they received certificates.
In December 2006, the product received the "High-tech Product" certificate issued by the Henan Provincial Science and Technology Department, and was included in the "China High-tech Product Export Catalog". The company was awarded the "High-tech Enterprise" and has been rated as a national "double-excellent" foreign investment enterprise for many years, and has been recognized as a "Foreign Capital Advanced Technology Enterprise" by the Provincial Department of Commerce.
After more than ten years of innovative development, the company has modern stainless steel pharmaceutical equipment, advanced Hewlett-Packard microelectronic inspection analysis and detection equipment, highly automated GMP standard workshops, an advanced team of pharmaceutical professionals, a strict quality assurance system, and established long-term technical cooperation relationships with Sichuan Antibiotics Research Institute, China Medical Group, Pharmaceutical Research Institute of Zhengzhou University, etc., has strong research and development strength. The company's products Rifamycin Sodium and Rifapentine passed the GMP certification implemented by the State Drug and Food Administration in 2004. In November 2009, it passed the recertification (Certificate No.: Yu K0098), and Rifapentine passed the European COS certification in December 2008. The company passed the new version of GMP certification in 2015. The products are registered in countries such as India, Ukraine, Russia, Brazil, Mexico, and are exported to Southeast Asia, Europe and other countries and regions, achieving good economic and social benefits.
People from the masses always practice the corporate philosophy of "century-old Minzhong, century-old fine products, green mountains always exist, and green water flows forever", bear the responsibility and mission of "making good medicines for the people", strengthen internal management, and pay close attention to product quality. Striving to develop new businesses, and striving to create better economic and social benefits.
The value of the masses: to be the talent needed by enterprises; to produce the products needed by the market; to be the enterprise needed by society!
Company Profile
Zhengzhou Minzhong Pharmaceutical Co., Ltd., established in 1994. We are devoting ourselves to manufacturing and dealing semi synthetic API antibiotic and its pharmaceutical products. Our main products, Rifamycin Sodium and Rifampicin, have the approval number in China, with GMP and the DMF; Our products are exported to many countries and regions. By improving internal management and quality, we are developing new business and working hard for the beautiful future.
Events
1994 Set up Minzhong Pharmceutical.
2003 won the second prize at the “ward for great technical advancement” and gain China Patent.
2004 Rifamycin Sodium and Rifampicin have acquired the GMP certificate.
2005 Acquired the national important new products certificate which issued by China Ministry of Science and Technology, China Ministry of Commerce, State Quality & Inspection Bureau of China.
2005 State Environmental Protection Administration of China.
2006 Won the “high-tech product” certificate, Listed in the China High-tech Exporting Products Directory. Comapany honored “high-tech enterprise”.
2008 Rifampicin passed the European COS authentication.
2009 Passed the GMP re-authentication.
2015 Passed the new GMP.
2020 Renewal of production license and obtaining GMP compliance documents
2024 Rifamycin sodium obtained WC certificate
2025 Kaifeng Minzhong Pharmaceutical Co., Ltd. starting production
China's Trusted Rifamycin API Manufacturer Since 1994
Zhengzhou Minzhong Pharmaceutical Co., Ltd. is a professional enterprise specializing in the research, production, and global distribution of semi-synthetic antibiotic APIs — serving pharmaceutical companies across 30+ countries with GMP-certified Rifamycin derivatives.
Zhengzhou Minzhong Pharmaceutical Co., Ltd., established in 1994, is a professional enterprise dedicated to the research, production, and global sales of semi-synthetic antibiotic raw materials and pharmaceutical products. Strategically located on the Zhengbian Industrial Belt in Henan Province, the company enjoys excellent connectivity via National Highway 107, the Beijing-Hong Kong-Macau Expressway, Longhai Railway, and is just 11 kilometers from Zhengzhou Xinzheng International Airport.
The company independently developed the "New Process for the Production of Rifapentine", which earned a national patent and the second prize for major scientific and technological progress in Henan Province in 2003. In 2005, the products were jointly recognized as "National Key New Products" by the Ministry of Science and Technology, the Ministry of Commerce, and other national agencies.
Minzhong Pharma maintains long-term technical cooperation with the Sichuan Antibiotics Research Institute, China Medical Group, and the Pharmaceutical Research Institute of Zhengzhou University, ensuring strong R&D capabilities and continuous innovation.
🔬
Advanced R&DPatented production processes
🏅
National RecognitionHigh-tech enterprise award
🤝
Research PartnershipsTop Chinese institutions
🌿
SustainabilityEco-friendly manufacturing
Our Product Portfolio
Premium Rifamycin Derivative APIs & Intermediates
Zhengzhou Minzhong Pharmaceutical manufactures a comprehensive range of active pharmaceutical ingredients and intermediates, all produced under strict GMP conditions and meeting international pharmacopoeia standards.
Active Pharmaceutical Ingredients (APIs)
💊
Rifampicin
CAS No. 13292-46-1
A first-line anti-tuberculosis antibiotic API widely used in the treatment of TB and other mycobacterial infections. Produced under GMP with European COS compliance.
A semi-synthetic antibiotic used as a key raw material in the production of various Rifamycin derivative drugs. GMP certified with DMF documentation available.
An ansamycin antibiotic used for the prevention and treatment of Mycobacterium avium complex (MAC) disease, particularly in immunocompromised patients.
A long-acting Rifamycin derivative for tuberculosis treatment. Minzhong's patented production process earned national recognition and European COS certification.
A non-absorbable antibiotic used for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. High-purity pharmaceutical grade.
A non-steroidal anti-inflammatory drug (NSAID) API used in the treatment of rheumatoid arthritis, osteoarthritis, and other inflammatory conditions.
API
Pharmaceutical Intermediates
⚗️
Rifamycin S
CAS No. 13553-79-2
A critical intermediate in the synthesis of various Rifamycin derivative antibiotics. Manufactured with high purity and consistent quality for downstream API production.
An important pharmaceutical intermediate used in the production pathway of Rifamycin-class antibiotics. Available in bulk quantities for industrial applications.
The sodium salt form of Rifamycin S, offering enhanced solubility for pharmaceutical manufacturing processes. Produced under strict quality control protocols.
With over three decades of specialized expertise, Zhengzhou Minzhong Pharmaceutical delivers unmatched quality, regulatory compliance, and global supply reliability.
🏆
30+ Years Expertise
Dedicated exclusively to Rifamycin derivatives since 1994, with patented production processes and deep domain knowledge.
🔬
Advanced R&D
State-of-the-art Hewlett-Packard analytical equipment, partnerships with leading Chinese research institutes, and continuous innovation.
✅
Triple Certified
GMP certified, European COS approved, and DMF holder — meeting the most stringent international pharmaceutical standards.
🌍
Global Reach
Products registered and exported to India, Russia, Brazil, Mexico, Europe, Southeast Asia, and 30+ countries worldwide.
Quality & Compliance
International Certifications & Registrations
Zhengzhou Minzhong Pharmaceutical maintains the highest quality standards with internationally recognized certifications, ensuring every API meets rigorous safety and efficacy requirements.
GMP Certification
Good Manufacturing Practice certification ensuring products are consistently produced and controlled according to the highest quality standards. First certified in 2004, with new-version GMP achieved in 2015.
European COS Certification
Certificate of Suitability to the European Pharmacopoeia (CEP/COS), confirming compliance with European quality standards. Rifapentine COS certified since December 2008.
DMF & Global Registrations
Drug Master File holder providing transparent manufacturing data for regulatory support. Products registered in India, Ukraine, Russia, Brazil, Mexico, and across Southeast Asia and Europe.
Manufacturing Excellence
State-of-the-Art GMP Production Facility
Zhengzhou Minzhong Pharmaceutical operates a modern manufacturing facility spanning over 5,000 square meters in Zhengzhou, China. The facility features modern stainless steel pharmaceutical equipment, highly automated GMP-standard workshops, and advanced Hewlett-Packard microelectronic inspection, analysis, and detection equipment.
Dedicated areas for raw material storage, production, quality control, and packaging ensure complete process integrity. The company also operates a second production base — Kaifeng Minzhong Pharmaceutical Co., Ltd. — which commenced production in 2025, further expanding manufacturing capacity.
5,000+
Sq. Meters
2
Production Bases
GMP
Standard
Our Journey
Three Decades of Pharmaceutical Excellence
From our founding in 1994 to becoming a globally recognized Rifamycin API manufacturer, every milestone reflects our commitment to quality and innovation.
1994
Company Founded
Zhengzhou Minzhong Pharmaceutical Co., Ltd. established as a professional Rifamycin derivatives manufacturer.
2003
National Patent & Award
"New Process for the Production of Rifapentine" won national patent and second prize for major scientific and technological progress in Henan Province.
2004
GMP Certification
Rifamycin Sodium and Rifampicin passed GMP certification from the State Drug and Food Administration.
2005
National Key New Products
Products jointly recognized as "National Key New Products" by four national ministries and administrations.
2006
High-Tech Enterprise
Received "High-tech Product" certificate and included in "China High-tech Product Export Catalog." Awarded "High-tech Enterprise" status.
2008
European COS Certification
Rifapentine passed the European Certificate of Suitability (COS) certification, opening doors to European pharmaceutical markets.
2015
New GMP Standard
Successfully passed the new-version GMP certification, demonstrating continued commitment to the highest manufacturing standards.
2020
License Renewal & GMP Compliance
Renewal of production license and obtaining updated GMP compliance documents.
2024
WC Certificate
Rifamycin Sodium obtained WC certificate, further strengthening global market access.
Zhengzhou Minzhong Pharmaceutical specializes in Rifamycin derivative APIs including Rifampicin (CAS 13292-46-1), Rifamycin Sodium (CAS 14897-39-3), Rifabutin (CAS 72559-06-9), Rifaximin (CAS 80621-81-4), Rifapentine (CAS 61379-65-5), and Piroxicam (CAS 36322-90-4). The company also produces pharmaceutical intermediates such as Rifamycin S, Rifamycin O, and Sodium Rifamycin S.
Yes. Zhengzhou Minzhong Pharmaceutical first obtained GMP certification in 2004, passed recertification in 2009 (Certificate No.: Yu K0098), and achieved new-version GMP certification in 2015. The company also holds European COS certification for Rifapentine (since 2008) and is a DMF holder, ensuring full regulatory compliance for global markets.
Minzhong Pharmaceutical exports its APIs to over 30 countries and regions including India, Ukraine, Russia, Brazil, Mexico, and numerous markets across Southeast Asia and Europe. Products are registered in multiple countries to ensure smooth regulatory compliance for international customers.
Minzhong Pharmaceutical stands out with over 30 years of exclusive focus on Rifamycin derivatives, a patented production process for Rifapentine, triple certification (GMP, COS, DMF), long-term partnerships with leading Chinese research institutions, and a 5,000+ square meter state-of-the-art manufacturing facility with two production bases. The company has been recognized as a national "High-tech Enterprise" and "double-excellent" foreign investment enterprise.
Yes. Zhengzhou Minzhong Pharmaceutical offers bespoke synthesis solutions ranging from small-scale research quantities to large-scale commercial production. The company's advanced synthesis capabilities, process optimization expertise, and state-of-the-art analytical laboratories enable them to meet unique client requirements across the Rifamycin product family.
You can request a quotation by contacting Minzhong Pharmaceutical directly via email at info@minzhongpharma.com, by phone at +86-371-65797114, or through WhatsApp/WeChat at +86 173 3535 0289. You can also fill out the inquiry form on this page or visit the official website at minzhongpharma.com/contact/ for additional contact options.
Ready to Source Premium Rifamycin APIs?
Partner with Zhengzhou Minzhong Pharmaceutical — 30+ years of trusted quality, GMP & COS certified, serving pharmaceutical companies in 30+ countries worldwide.